PNC Financial Services Group
STLN

PNC Financial Services Group’s Starling Oncology STLN Stock Holding History

PNC Financial Services Group’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39K Buy
625
+10
+2% +$42 ﹤0.01% 4523
2026
Q1 		$1.89K Buy
615
+453
+280% +$1.39K ﹤0.01% 4601
2025
Q4 		$577 Buy
162
+10
+7% +$37 ﹤0.01% 4802
2025
Q3 		$530 Buy
+152
New +$521 ﹤0.01% 4795

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PNC Financial Services Group's STLN Position: Q2 2026 in Review

PNC Financial Services Group increased its Starling Oncology (STLN) stake by 1.6% in Q2 2026, buying an estimated $42 and bringing the position to 625 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #4523.

PNC Financial Services Group first reported a position in STLN in Q3 2025 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • PNC Financial Services Group held 625 shares of Starling Oncology worth $3.39K as of Q2 2026.
  • PNC Financial Services Group bought 10 Starling Oncology shares in Q2 2026, an estimated $42.
  • Starling Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4523 holding.
  • PNC Financial Services Group first reported a position in Starling Oncology in Q3 2025 and has held it in 4 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.